会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • NOVEL HYDROLASE PROTEIN
    • 新型水解蛋白
    • US20130130338A1
    • 2013-05-23
    • US13813047
    • 2011-08-31
    • Hiroshi KawabataRyoma MiyakeKuniko AsadaRyouhei Katou
    • Hiroshi KawabataRyoma MiyakeKuniko AsadaRyouhei Katou
    • C12N9/14C12P7/62
    • C12P7/62C12N9/14C12N9/18C12P41/005Y02P20/52
    • It is an object of the present invention to provide a novel hydrolase, which is used when dialkyl 2-vinylcyclopropane-1,1-dicarboxylate is hydrolyzed with an enzyme, so as to efficiently obtain (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid that is useful as an intermediate for synthesizing therapeutic agents for hepatitis C. According to the present invention, there is provided a hydrolase protein, which consists of the amino acid sequence shown in any one of SEQ ID NOS. 2 to 5 and which has activity of catalyzing, at higher selectivity than the protein consisting of the amino acid sequence shown in SEQ ID NO. 1, a reaction of producing (1S,2S)-1-ethoxycarbonyl-2-vinylcyclopropanecarboxylic acid from diethyl 2-vinylcyclopropane-1,1-dicarboxylate.
    • 本发明的一个目的是提供一种新的水解酶,其在2-乙烯基环丙烷-1,1-二羧酸二烷基酯用酶水解时使用,以有效地获得(1S,2S)-1-烷氧基羰基-2 - 乙烯基环丙烷羧酸,其可用作合成丙型肝炎治疗剂的中间体。根据本发明,提供了水解酶蛋白质,其由SEQ ID NOS中任一项所示的氨基酸序列组成。 2至5,并且其具有以比由SEQ ID NO。所示的氨基酸序列组成的蛋白质更高的选择性催化的活性。 1,由2-乙烯基环丙烷-1,1-二羧酸二乙酯生成(1S,2S)-1-乙氧基羰基-2-乙烯基环丙烷羧酸的反应。
    • 3. 发明授权
    • Hydrolase protein
    • 水解酶蛋白
    • US09029107B2
    • 2015-05-12
    • US13813047
    • 2011-08-31
    • Hiroshi KawabataRyoma MiyakeKuniko AsadaRyouhei Katou
    • Hiroshi KawabataRyoma MiyakeKuniko AsadaRyouhei Katou
    • C12N9/14C12P7/62C12N9/18C12P41/00
    • C12P7/62C12N9/14C12N9/18C12P41/005Y02P20/52
    • It is an object of the present invention to provide a novel hydrolase, which is used when dialkyl 2-vinylcyclopropane-1,1-dicarboxylate is hydrolyzed with an enzyme, so as to efficiently obtain (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid that is useful as an intermediate for synthesizing therapeutic agents for hepatitis C. According to the present invention, there is provided a hydrolase protein, which consists of the amino acid sequence shown in any one of SEQ ID NOS. 2 to 5 and which has activity of catalyzing, at higher selectivity than the protein consisting of the amino acid sequence shown in SEQ ID NO. 1, a reaction of producing (1S,2S)-1-ethoxycarbonyl-2-vinylcyclopropanecarboxylic acid from diethyl 2-vinylcyclopropane-1,1-dicarboxylate.
    • 本发明的一个目的是提供一种新的水解酶,其在2-乙烯基环丙烷-1,1-二羧酸二烷基酯用酶水解时使用,以有效地获得(1S,2S)-1-烷氧基羰基-2 - 乙烯基环丙烷羧酸,其可用作合成丙型肝炎治疗剂的中间体。根据本发明,提供了水解酶蛋白质,其由SEQ ID NOS中任一项所示的氨基酸序列组成。 2至5,并且其具有以比由SEQ ID NO。所示的氨基酸序列组成的蛋白质更高的选择性催化的活性。 1,由2-乙烯基环丙烷-1,1-二羧酸二乙酯生成(1S,2S)-1-乙氧基羰基-2-乙烯基环丙烷甲酸的反应。